A dramatic response to long-acting octreotide in metastatic hepatocellular carcinoma.
Deming
Dustin A
DA
University of Wisconsin Comprehensive Cancer Center, 600 Highland Ave., Madison, Wisconsin 53792-5666, USA.
Stella
Amy L
AL
Holen
Kyle D
KD
Ku
Geoffrey
G
O'Reilly
Eileen M
EM
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004417:Dyspnea / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D008103:Liver Cirrhosis; D008113:Liver Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D011859:Radiography
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide